Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aidan Synnott
CEO | Chief Executive Officer | 48 | 10/04/2025 |
Fabrice Viviani
CEO | Chief Executive Officer | - | 04/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 23/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 13/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 02/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 23/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 24/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% | ||
| 24/10/22 | Sell | Head of Human Resources | 18,140 | 0.2649% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -0.14% | - | - | 105M | ||
| +1.07% | -3.49% | -3.25% | +12.87% | 46.86B | ||
| +0.25% | +1.65% | +408.41% | +629.49% | 40.23B | ||
| -0.27% | +4.45% | +9.93% | +66.92% | 36.23B | ||
| +0.35% | +0.87% | +3.60% | -8.81% | 34.72B | ||
| +3.14% | +1.02% | +3.37% | +38.15% | 27.89B | ||
| -0.73% | +11.84% | +31.97% | +143.53% | 16.79B | ||
| +0.47% | -2.74% | - | - | 16.74B | ||
| +0.42% | -5.52% | +0.76% | +8.50% | 13.12B | ||
| -2.68% | -2.49% | -15.00% | -31.68% | 12.7B | ||
| Average | +0.20% | +0.83% | +54.97% | +107.37% | 27.25B | |
| Weighted average by Cap. | +0.48% | +0.91% | +75.32% | +136.64% |
Employees
236
















